Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Patient Safety Competency-Building Program for Healthcare Professionals in Pediatric Cardiac Critical Care in Ethiopia

28. September 2026 aktualisiert von: Woong-Han Kim

Development and Evaluation of a Patient Safety Competency-Building Program for Healthcare Professionals in Pediatric Cardiac Critical Care in Ethiopia

This study aims to develop and evaluate a patient safety competency-building program for healthcare professionals involved in pediatric cardiac critical care in Ethiopia. The program consists of educational modules addressing key areas of patient safety and is delivered in person at a tertiary hospital in Addis Ababa, Ethiopia. Patient safety competence is assessed before and immediately after each training round, and acceptability, appropriateness, and feasibility are assessed immediately after each training round as implementation outcomes.

Studienübersicht

Status

Aktiv, nicht rekrutierend

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

The patient safety competency-building program comprises nine educational modules delivered across three training rounds, with selected modules provided during each round. Healthcare professionals involved in pediatric cardiac critical care may participate in one or more training rounds, and participants may therefore differ across rounds. For each training round, patient safety competence is assessed before the training and immediately after its completion as a common educational outcome. Medication safety competence is assessed before and immediately after the first training round as a round-specific educational outcome. Acceptability, appropriateness, and feasibility are assessed immediately after each training round as implementation outcomes.

Studientyp

Interventionell

Einschreibung (Geschätzt)

41

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Addis Ababa
      • Addis Ababa, Addis Ababa, Äthiopien
        • Tikur Anbessa Specialized Hospital

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Healthcare professionals involved in pediatric cardiac critical care at Tikur Anbessa Specialized Hospital, including physicians, nurses, perfusionists, and other relevant healthcare professionals
  • Able to understand the purpose and procedures of the study and voluntarily provide informed consent

Exclusion Criteria:

  • Healthcare professionals who are on leave or are not directly involved in pediatric cardiac critical care at the time of the study
  • Individuals who are unable to adequately understand or participate in the educational program conducted in English, even with Amharic language support

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Versorgungsforschung
  • Zuteilung: N / A
  • Interventionsmodell: Einzelgruppenzuweisung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Patient Safety Competency-Building Program

Participants receive a patient safety competency-building program designed for healthcare professionals involved in pediatric cardiac critical care. The program comprises nine educational modules and is delivered in person across three training rounds, with selected patient safety modules provided during each round.

The patient safety competency-building program consists of nine educational modules: Patient Safety Principles; Teamwork and Communication; Surgical Safety; Medication Safety; Blood Transfusion Safety; Infection Control; Patient Assessment and Clinical Decision-Making; Safety Equipment Management; and Patient Safety Incident Response and Reporting. Selected modules are delivered during each training round through in-person lectures, group discussions, and practical activities.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Patient Safety Competence
Zeitfenster: Before and immediately after each training round

Patient safety competence is measured using the Health Professional Education in Patient Safety Survey (H-PEPSS), a 16-item self-report instrument covering six domains: working in teams with other health professionals, communicating effectively, managing safety risks, understanding human and environmental factors, recognizing and responding to adverse events, and culture of safety. Scores are calculated as the mean of the 16 items, with possible scores ranging from 1 to 5; higher scores indicate greater perceived patient safety competence.

Before and immediately after each training round

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Medication Safety Competence
Zeitfenster: Before and immediately after the first training round

Medication safety competence is measured using the Medication Safety Competence Scale (MSCS), a 36-item self-report instrument covering six domains: patient-centered medication management, improvement of safety problems, management of effecting factors, safety risk management, multidisciplinary collaboration, and responsibility in the nursing profession. Scores are calculated as the mean of the 36 items, with possible scores ranging from 1 to 5; higher scores indicate greater medication safety competence.

Before and immediately after the first training round

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Acceptability of the Intervention
Zeitfenster: Immediately after each training round

Acceptability is measured using the Acceptability of Intervention Measure (AIM). The AIM consists of four items rated on a 5-point Likert scale. Scores are calculated as the mean of the four items, ranging from 1 to 5; higher scores indicate greater acceptability of the intervention.

Immediately after each training round
Appropriateness of the Intervention
Zeitfenster: Immediately after each training round

Appropriateness is measured using the Intervention Appropriateness Measure (IAM). The IAM consists of four items rated on a 5-point Likert scale. Scores are calculated as the mean of the four items, ranging from 1 to 5; higher scores indicate greater perceived appropriateness of the intervention.

Immediately after each training round
Feasibility of the Intervention
Zeitfenster: Immediately after each training round

Feasibility is measured using the Feasibility of Intervention Measure (FIM). The FIM consists of four items rated on a 5-point Likert scale. Scores are calculated as the mean of the four items, ranging from 1 to 5; higher scores indicate greater perceived feasibility of the intervention.

Immediately after each training round
Program Satisfaction
Zeitfenster: Immediately after each training round

Program satisfaction is assessed using a questionnaire developed by the research team. The questionnaire includes 5-point ratings of overall satisfaction, individual educational sessions, and five aspects of the educational experience, as well as a 10-point rating of achievement of the program objectives. Higher scores indicate more favorable evaluations. Open-ended questions are included to obtain additional participant feedback.

Immediately after each training round

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Ermittler

  • Hauptermittler: Woong-Han Kim, MD, PhD, Seoul National University Hospital

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

7. August 2026

Primärer Abschluss (Geschätzt)

1. Dezember 2027

Studienabschluss (Geschätzt)

1. Dezember 2027

Studienanmeldedaten

Zuerst eingereicht

21. September 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

21. September 2026

Zuerst gepostet (Tatsächlich)

28. September 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

1. Oktober 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

28. September 2026

Zuletzt verifiziert

1. August 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • H-2607-045-1764

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .